4//SEC Filing
Beetham Thomas W. 4
Accession 0001179110-21-003615
CIK 0001730430other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:07 PM ET
Size
7.7 KB
Accession
0001179110-21-003615
Insider Transaction Report
Form 4
Beetham Thomas W.
Chief Legal Officer10% Owner
Transactions
- Award
Restricted Share Units
2021-03-16+8,769→ 8,769 total→ Class A Common Shares (8,769 underlying) - Award
Share Option
2021-03-16+52,611→ 52,611 totalExercise: $22.89Exp: 2031-03-15→ Class A Common Shares (52,611 underlying)
Footnotes (3)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021.
- [F2]Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.
- [F3]The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001741382
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:07 PM ET
- Size
- 7.7 KB